中国实用医刊
中國實用醫刊
중국실용의간
Chinese Journal of Practical Medicine
2015年
22期
20-21
,共2页
心力衰竭%美托洛尔片%呋塞米片%临床疗效
心力衰竭%美託洛爾片%呋塞米片%臨床療效
심력쇠갈%미탁락이편%부새미편%림상료효
Heart failure%Metoprolol%Furosemide%Clinical efficacy
目的:探讨美托洛尔联合呋塞米治疗心力衰竭患者的临床效果。方法回顾性分析武陟县第二人民医院2012年1月至2014年1月收治的86例心功能Ⅲ~Ⅳ级心力衰竭患者的临床资料,根据治疗方法的不同将患者随机分成对照组和治疗组,每组43例,对照组给予单纯呋塞米治疗,治疗组给予美托洛尔联合呋塞米治疗。比较两组患者的临床治疗效果和不良反应的发生情况。结果对照组治疗有效率为81.40%,治疗组为95.35%,治疗组有效率明显高于对照组(P<0.05);对照组不良反应发生率为20.93%,治疗组为4.65%,治疗组不良反应发生率明显低于对照组( P<0.05)。结论对于心功能Ⅲ~Ⅳ级的心力衰竭患者,临床上给予美托洛尔联合呋塞米治疗的效果较好,能够明显提高临床治疗有效率,同时不良反应少,值得临床广泛推广使用。
目的:探討美託洛爾聯閤呋塞米治療心力衰竭患者的臨床效果。方法迴顧性分析武陟縣第二人民醫院2012年1月至2014年1月收治的86例心功能Ⅲ~Ⅳ級心力衰竭患者的臨床資料,根據治療方法的不同將患者隨機分成對照組和治療組,每組43例,對照組給予單純呋塞米治療,治療組給予美託洛爾聯閤呋塞米治療。比較兩組患者的臨床治療效果和不良反應的髮生情況。結果對照組治療有效率為81.40%,治療組為95.35%,治療組有效率明顯高于對照組(P<0.05);對照組不良反應髮生率為20.93%,治療組為4.65%,治療組不良反應髮生率明顯低于對照組( P<0.05)。結論對于心功能Ⅲ~Ⅳ級的心力衰竭患者,臨床上給予美託洛爾聯閤呋塞米治療的效果較好,能夠明顯提高臨床治療有效率,同時不良反應少,值得臨床廣汎推廣使用。
목적:탐토미탁락이연합부새미치료심력쇠갈환자적림상효과。방법회고성분석무척현제이인민의원2012년1월지2014년1월수치적86례심공능Ⅲ~Ⅳ급심력쇠갈환자적림상자료,근거치료방법적불동장환자수궤분성대조조화치료조,매조43례,대조조급여단순부새미치료,치료조급여미탁락이연합부새미치료。비교량조환자적림상치료효과화불량반응적발생정황。결과대조조치료유효솔위81.40%,치료조위95.35%,치료조유효솔명현고우대조조(P<0.05);대조조불량반응발생솔위20.93%,치료조위4.65%,치료조불량반응발생솔명현저우대조조( P<0.05)。결론대우심공능Ⅲ~Ⅳ급적심력쇠갈환자,림상상급여미탁락이연합부새미치료적효과교호,능구명현제고림상치료유효솔,동시불량반응소,치득림상엄범추엄사용。
Objective To investigate the effect of metoprolol combined with furosemide on pa-tients with heart failure.Methods The clinical data of 86 heart faiure patients with cardiac function stage Ⅲ-Ⅳfrom January 2012 to January 2014 were retrospectively analyzed.Depending on the method of treatment, the patients were randomly divided into the control group and the treatment group, with 43 cases in each group.The patients in the control group were treated with metoprolol alone, and the pa-tients in treatment group were treated with metoprolol combined with furosemide.The clinical effects and adverse reactions were compared.Results The effective rate in control group was 81.40%, and the ef-fective rate in treatment group was 95.35%, there was significant difference ( P<0.05 ) .The incidence of adverse reactions in control group was 20.93%, and that in treatment group was 4.65%, there was significant difference ( P<0.05 ) .Conclusions For heart failure patients with cardiac function stageⅢ-Ⅳ, metoprolol combined with furosemide therapy has better effect, can significantly improve the clinical efficiency, has fewer adverse reactions, it is worthy of widespread in clinics.